Truist Financial’s Ultragenyx Pharmaceutical RARE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $200K | Sell |
5,503
-4,080
| -43% | -$148K | ﹤0.01% | 2399 |
|
|
2025
Q1 | $347K | Sell |
9,583
-1,103
| -10% | -$39.9K | ﹤0.01% | 2051 |
|
|
2024
Q4 | $450K | Sell |
10,686
-1,615
| -13% | -$67.9K | ﹤0.01% | 1933 |
|
|
2024
Q3 | $683K | Buy |
12,301
+2,510
| +26% | +$139K | ﹤0.01% | 1698 |
|
|
2024
Q2 | $402K | Sell |
9,791
-319
| -3% | -$13.1K | ﹤0.01% | 2097 |
|
|
2024
Q1 | $472K | Sell |
10,110
-1,613
| -14% | -$75.3K | ﹤0.01% | 1987 |
|
|
2023
Q4 | $561K | Sell |
11,723
-7,291
| -38% | -$349K | ﹤0.01% | 1895 |
|
|
2023
Q3 | $678K | Sell |
19,014
-599
| -3% | -$21.4K | ﹤0.01% | 1749 |
|
|
2023
Q2 | $905K | Buy |
19,613
+4,726
| +32% | +$218K | ﹤0.01% | 1630 |
|
|
2023
Q1 | $597K | Buy |
14,887
+655
| +5% | +$26.3K | ﹤0.01% | 1859 |
|
|
2022
Q4 | $659K | Buy |
14,232
+2,710
| +24% | +$126K | ﹤0.01% | 1768 |
|
|
2022
Q3 | $477K | Buy |
11,522
+3,883
| +51% | +$161K | ﹤0.01% | 1836 |
|
|
2022
Q2 | $456K | Sell |
7,639
-65
| -0.8% | -$3.88K | ﹤0.01% | 1954 |
|
|
2022
Q1 | $559K | Buy |
7,704
+1,318
| +21% | +$95.6K | ﹤0.01% | 1939 |
|
|
2021
Q4 | $537K | Buy |
6,386
+7
| +0.1% | +$589 | ﹤0.01% | 1954 |
|
|
2021
Q3 | $575K | Buy |
6,379
+195
| +3% | +$17.6K | ﹤0.01% | 1903 |
|
|
2021
Q2 | $590K | Sell |
6,184
-323
| -5% | -$30.8K | ﹤0.01% | 1936 |
|
|
2021
Q1 | $741K | Buy |
6,507
+391
| +6% | +$44.5K | ﹤0.01% | 1746 |
|
|
2020
Q4 | $846K | Buy |
6,116
+863
| +16% | +$119K | ﹤0.01% | 1557 |
|
|
2020
Q3 | $432K | Buy |
5,253
+654
| +14% | +$53.8K | ﹤0.01% | 1779 |
|
|
2020
Q2 | $360K | Buy |
+4,599
| New | +$360K | ﹤0.01% | 1808 |
|